Sevelamer Carbonate Tablet, Film Coated
Product Images NDC 51407-706

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Sevelamer Carbonate (NDC 51407-706). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51407-706-27ol (Sevelamer Tablets 800 mg)

This is a description of Sevelamer Carbonate Tablets, each containing 800 mg of active ingredient. The usual dosage information can be found in the package insert. It is recommended to store the tablets in a tight container, protect from moisture, and keep out of reach of children. The tablets should be stored at a temperature between 20°C - 25°C (68°F - 77°F). Made in India and marketed by GSMS, Incorporated.*

FDA Label Image

Figure2 (Figure 2)

FDA Label Image

Figure1 (Figure1)

FDA Label Image

Figure3 (Figure3)

This text contains information related to a reduction in serum phosphorus levels, possibly linked to a certain treatment or intervention. The data may be illustrating a change in serum phosphorus levels over time or in response to a specific study, as indicated by the inclusion of the term "Reduction from Baseline." The values and labels mentioned suggest a quantitative analysis of serum phosphorus levels measured in milligrams per deciliter (mg/dL).*

FDA Label Image

Figure4 (Figure4)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.